US Stock MarketDetailed Quotes

IXHL Incannex Healthcare

Watchlist
  • 3.590
  • +0.390+12.19%
Close Mar 28 16:00 ET
  • 3.540
  • -0.050-1.39%
Post 19:38 ET
56.98MMarket Cap2.27P/E (TTM)

About Incannex Healthcare Company

Incannex Healthcare, Inc. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It operates through the following segments: Psychedelic Products, Cannabinoid Products, and Corporate. The Psychedelic Products segment is involved in the use of psychedelic medicine and therapies for the treatment of mental health disorders. The Cannabinoid Products segment focuses on the use of medicinal cannabinoid products. The Corporate segment includes management of the organization, capital management, and management of resources. The company was founded on April 27, 2001 and is headquartered in New York, NY.

Company Profile

SymbolIXHL
Company NameIncannex Healthcare
Listing Date03/02/2022
Founded2001
CEOMr. Joel Latham
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends06-30
Address18 East 50th Street,5th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10022

Company Executives

  • Name
  • Position
  • Salary
  • Joel Latham
  • Director, Chief Executive Officer and President
  • 3.03M
  • Lekhram Changoer
  • Chief Technology Officer
  • 157.50K
  • Joseph Swan
  • Treasurer, Controller, Principal Accounting Officer, Chief Financial Officer and Secretary
  • --
  • Troy Valentine
  • Chairman of the Board
  • 1.38M
  • Dr. George E. Anastassov
  • Director
  • 175.87K
  • Peter Widdows
  • Independent Director
  • 316.23K
  • Robert Clark
  • Independent Director
  • 176.09K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg